7Baggers
 James Huang to join CASI Pharmaceuticals board as independent director  Investing.com Fri, 26 Sep 2025 14:27:57 GMT
 Casi Pharmaceuticals appoints James Hunag to board of directors  TipRanks Fri, 26 Sep 2025 14:05:29 GMT
 CASI Pharmaceuticals Appoints James Huang to Board of Directors  ACCESS Newswire Fri, 26 Sep 2025 13:50:42 GMT
 published on: 2025-09-15 01:47:21  newser.com Mon, 15 Sep 2025 06:47:21 GMT
 CASI Pharmaceuticals advances anti-CD38 antibody in ITP trial By Investing.com  Investing.com Nigeria Mon, 08 Sep 2025 07:00:00 GMT
 hc wainwright analysts raise earnings estimates for casi  Defense World Sat, 06 Sep 2025 05:04:04 GMT
 what is hc wainwright’s forecast for casi q1 earnings?  Defense World Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 01:58:36  Newser Thu, 04 Sep 2025 06:58:36 GMT
 CASI Pharmaceuticals Strengthens Board with New Appointment  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 casi pharmaceuticals second quarter 2025 earnings: misses expectations  Yahoo Finance Sun, 31 Aug 2025 07:00:00 GMT
 published on: 2025-08-30 21:47:17  Newser Sun, 31 Aug 2025 02:47:17 GMT
 published on: 2025-08-29 16:06:43  Newser Fri, 29 Aug 2025 21:06:43 GMT
 published on: 2025-08-28 03:48:26  Newser Thu, 28 Aug 2025 08:48:26 GMT

CASI Pharmaceuticals, Inc
(NASDAQ:CASI) 

CASI stock logo

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell t...

Founded: 1991
Full Time Employees: 125
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends